24/7 eTV BreakingNewsShow : Dzvanya pane bhatani rezwi (kuruboshwe kuruboshwe rwevhidhiyo)
Dzvanya apa kana iri pepanhau rako!

Novavax Misoro kuWorld Vaccine Congress Europe

rakanyorwa mupepeti

Biotechnology kambani Novavax, Inc. iyo yakatsaurirwa mukuvandudza nekutengesa majekiseni echizvarwa chinotevera chezvirwere zvakakomba zvinotapukira, nhasi yazivisa kuti Vivek Shinde, MD, Mutevedzeri weMutungamiri, Clinical Development, ichaendesa hurukuro panguva yeWorld Vaccine Congress Europe 2021.

Print Friendly, PDF & Email

Musoro wehurukuro ichave yeNovavax 'COVID-NanoFlu ™ Combination Vaccine, iyo inosanganisa iyo kambani inogadzirisazve nanoparticle protein-based COVID-19 uye NanoFlu ™ vachengeti vanodzora neMatrix-M ™ adjuvant mune imwechete fomati.       

Zvinyorwa zveSession zvinotevera:

Zuva: Chitatu, Gumiguru 20, 2021
Nguva: 11:30 am - 12:00 pm Central Europe Nguva (CET) /
 
5:30 am - 6:00 am Eastern Daylight Time (EDT)
Musoro: Kwidziridzo paNovavax 'NanoFlu jekiseni uye COVID-19-NanoFlu Kubatanidzwa Kwekudzivirira
Novavax Mutori wechikamu: Vivek Shinde, MD, Mutevedzeri weMutungamiri, Clinical Development
 
 

Iyo yekambani inobata recombinant tekinoroji chikuva inosanganisa iyo simba uye kumhanya kwemajini ekugadzira kuti ibudirire kuburitsa yakanyanya immunogenic nanoparticles yakagadzirirwa kugadzirisa inokurumidza hutano hwepasirese zvido. Novavax irikuitisa kwayedza-nhanho kiriniki miedzo yeNVX-CoV2373, mukwikwidzi wayo wekurwisa SOSS-CoV-2, hutachiona hunokonzera COVID-19. NanoFlu ™, iyo quadrivalent influenza nanoparticle jekiseni, yakasangana nezvose zvakakosha muzvikamu zvayo zvakakosha zveChipiri 3 kiriniki kutongwa kune vakuru vakuru. Vavhoti vese vari vaviri vanosanganisira Novavax 'proprietary saponin-based Matrix-M ™ adjuvant yekumisikidza immune immune uye kukurudzira mwero wepamusoro wekudzora masoja ekudzivirira.

Print Friendly, PDF & Email

Nezvomunyori

mupepeti

Mupepeti mukuru ndiLinda Hohnholz.

Leave a Comment